Results 171 to 180 of about 86,281 (261)

Disease‐free survival as a surrogate outcome for localized kidney cancer—A systematic review and meta‐analysis

open access: yesCancer, Volume 132, Issue 16, 15 August 2026.
Abstract Background Disease‐free survival (DFS) is commonly used as a primary end point in trials for localized renal cell carcinoma (RCC), although its validity as a surrogate for overall survival (OS) remains uncertain. The objective of this study was to evaluate whether DFS is a reliable surrogate end point for OS in this setting.
Constanza Martinez   +7 more
wiley   +1 more source

Salvage therapies for local recurrence of renal cell carcinoma: a systematic review and meta-analysis. [PDF]

open access: yesWorld J Urol
Suleja A   +16 more
europepmc   +1 more source

Retroperitoneoscopic Approach in Live Donor Left Nephrectomy: Insights From a Single-Center Case Series in the Sub-Himalayan Region. [PDF]

open access: yesCureus
Singh K   +10 more
europepmc   +1 more source

Clinical characteristics and follow‐up of 77 patients with pathogenic fumarate hydratase variants

open access: yes
BJU International, Volume 138, Issue 3, Page 397-399, September 2026.
Matthijs Duijn   +12 more
wiley   +1 more source

Feasibility of simultaneous donor nephrectomy and kidney transplantation using a shared single-port robotic platform. [PDF]

open access: yesJ Robot Surg
Siddiqui HU   +8 more
europepmc   +1 more source

Late recurrence after radical nephrectomy for renal cell carcinoma in a patient with horseshoe kidney: a case report. [PDF]

open access: yesInt J Surg Case Rep
Maddah G   +5 more
europepmc   +1 more source

Iatrogenic aortic and iliac artery transections during robotic nephrectomies requiring emergent open vascular repair. [PDF]

open access: yesJ Vasc Surg Cases Innov Tech
Lightfoot C   +5 more
europepmc   +1 more source

Long-Term Risk for Scrotal Hydrocelectomy After Laparoscopic Living Donor Nephrectomy: A Population-Based Matched Cohort Study. [PDF]

open access: yesCan J Kidney Health Dis
Garg AX   +14 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy